November 1, Friday (Day 5)
Session 1: Discovery
Describe the principles of basic immunology. Describe the process of vaccine discovery
09:00-09:30 | Historical overview of vaccine Discovery Professor Dr. Kenji Hirayama, Nagasaki University, Japan |
09:30-10:30 | Vaccines for infection control Professor Dr. Kenji Hirayama, Nagasaki University, Japan |
10:30-10:45 | Break |
10:45-12:15 | Vaccines for infection control Professor Dr. Kenji Hirayama, Nagasaki University, Japan |
12:15-13:30 | Lunch |
13:30-14:30 | Vaccine Platform Technology and Adjuvant Development (Dr.Arakawa) Dr. Takeshi Arakawa, University of the Ryukyus, Japan |
Session 2: Pre-Clinical Development
Describe the process of pre-clinical development of vaccine
14:30-15:00 | CMC Dr. Takeshi Arakawa, University of the Ryukyus, Japan |
15:00-15:15 | Break |
15:15-15:45 | Immunogenicity and protect activity assessment Dr. Takeshi Arakawa, University of the Ryukyus, Japan |
15:45-16:30 | Safety assessment:Toxicity test in animals: regional complications, systemic toxicity Dr. Takeshi Arakawa, University of the Ryukyus, Japan |
November 4, Monday (Day 6)
Session 3: Clinical Development
Describe the process of vaccine clinical development
09:00-10:00 | Assessment of pre-clinical information TBD |
10:00-10:30 | Clinical development plan TBD |
10:30-10:45 | Break |
10:45-11:45 | Dose selection and regimen TBD |
11:45-13:30 | Lunch |
13:30-15:45 | Case studies Professor Dr. Kenji Hirayama, Nagasaki University, Japan |
15:45-16:00 | Break |
16:00-17:00 | Rev and Exam 3 (Module 3) Professor Dr. Kenji Hirayama, Nagasaki University, Japan |